Naringenin reduced tumor incidence and tumor burden, reduced thiobarbituric acid reactive substances (TBARS), protein carbonyl and nitrate levels, down-regulated superoxide dismutase (SOD) and catalase expression, and up-regulated glutathione reductase (GR) and glutathione peroxidase (GPx) expression. The gene discussed is SOD1; the disease is neoplasm.